Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience

Ann Allergy Asthma Immunol. 2015 Dec;115(6):536. doi: 10.1016/j.anai.2015.09.012.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-Allergic Agents / therapeutic use*
  • Chronic Disease
  • Female
  • Humans
  • Male
  • Omalizumab / therapeutic use*
  • Treatment Outcome
  • Urticaria / drug therapy*

Substances

  • Anti-Allergic Agents
  • Omalizumab